Aspirin in primary prevention: a case for selective use

Journal of Cardiovascular Pharmacology · Published 2026-06-05 · DOI 10.1097/fjc.0000000000001841

Free full text

Authors (5)

Myra Lewontin, Antonio Abbate, Todd C. Villines, David Guarraia, Michael Ayers

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Lewontin, M., Abbate, A., Villines, T., et al. (2026). Aspirin in primary prevention: a case for selective use. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0000000000001841

Related articles

• Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• Melissa officinalis extract attenuates gamma radiation-induced cardiac injury in rats: An integrated bioinformatics and experimental study · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• Magnitude of blood pressure reduction in response to levosimendan infusion independently predicts in-hospital mortality in patients with acute heart failure · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• Imipramine Can Block Human Cardiac H1-Histamine Receptors · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• The Cardiac Sarcomere: From development of heritable cardiomyopathies to gene and precision therapies · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• Human Histamine-1 Receptor Antagonism by Imipramine: Bridging Experimental Models and Clinical Cardiotoxicity · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• Safety and effectiveness of somatostatin and analogues on chest tube output after coronary artery bypass grafting: A scoping review · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• Reversal of the Anticoagulant Effect of Milvexian by 4-Factor PCC and rFVIIa in Healthy Participants: a Two-Part, Randomized, Crossover Study · Journal of Cardiovascular Pharmacology · 2026 · Same journal
• Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study · Journal of Cardiovascular Pharmacology · 2026 · Same journal